Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 19, 2026
FuelCell Energy (FCEL): Can the Stock Reach $25 on Its AI Data Center Pipeline?

FuelCell Energy (FCEL): Can the Stock Reach $25 on Its AI Data Center Pipeline?

Key Takeaways

  • Price Target in Focus: FCEL closed at $18.50 on July 17, 2026. Reaching $25 would require a roughly 35% advance from current levels — a move the stock has demonstrated it can make during its volatile rallies.
  • Strongest Bullish Catalyst: A 4-gigawatt commercial pipeline, with approximately 89% of proposals tied to AI data center power demand, represents the core growth narrative driving institutional interest.
  • Fit Energy Deal Provides Visibility: The strategic agreement to supply up to 380 megawatts of fuel cell power to data centers gives the company its most concrete revenue pathway yet, with initial 30 MW deployment expected later in 2026.
  • Persistent Profitability Challenges: FCEL reported a net loss of $77.6 million on revenues of just $35.6 million in its most recent quarter, underscoring that the path from pipeline to profits remains unproven.
  • Analyst Consensus Is Mixed: Wall Street's average 12-month price target sits near $22–$25, with high estimates reaching $32. The $25 level aligns closely with the upper end of the consensus range and represents a key battleground for bulls and skeptics alike.

Why the $25 Level Matters for FCEL Investors

The $25 price point has emerged as a psychologically significant target for FuelCell Energy, Inc. (FCEL). It sits near the upper band of Wall Street's consensus analyst price target range and represents a level the stock has crossed multiple times during its extraordinary rally from under $4 to nearly $38 over the past year. After pulling back more than 50% from its 52-week high of $37.88, FCEL now trades at $18.50. The question confronting investors is whether the pullback represents a buying opportunity ahead of another push toward $25 and beyond — or whether the stock has already priced in its best-case scenario.

Company Overview

FuelCell Energy, based in Danbury, Connecticut, designs, manufactures, and operates stationary fuel cell platforms for clean electric power generation. The company's technology converts hydrogen and natural gas into electricity through an electrochemical process, offering an alternative to traditional grid power. Its platforms also include carbon capture capabilities and hydrogen production systems. Under CEO Jason Few, FCEL has pivoted aggressively toward the data center market, positioning its technology as a solution for AI-driven power demand that the traditional electrical grid cannot satisfy quickly enough.

Drivers That Could Push FCEL Toward $25

The bull case for reaching $25 rests primarily on the company's data center opportunity. During the fiscal second quarter, management disclosed that its pipeline of submitted proposals surged 267% sequentially to 4 gigawatts, with data center customers representing roughly 89% of that total. The average deal size doubled from 65 megawatts to 130 megawatts, signaling growing interest from larger-scale operators.

The Fit Energy agreement provides the most tangible validation of this strategy. The multi-phase deal covers up to 380 megawatts of clean baseload power, structured with an initial 30 MW commitment and options for subsequent phases of 100 MW and two 125 MW tranches. Each phase is anchored by 15-to-20-year service agreements, which would meaningfully improve long-term revenue visibility if executed.

Several major Wall Street firms have responded with upgrades. UBS raised its rating to Buy and lifted its price target to $27, while Jefferies upgraded to Buy with a $24 target. B. Riley went further, raising its target to $32. These analyst moves reflect growing confidence that FCEL can convert its pipeline into contracted backlog. The company's collaboration with Siemens on scalable fuel cell power systems and a $49 million EXIM Bank financing package for Korean deliveries add further credibility to the expansion narrative.

Risks and Challenges Facing the Stock

The bear case is rooted in financial reality. In the most recent quarter, FCEL generated only $35.6 million in revenue — a 5% year-over-year decline — while posting a gross loss of $12.9 million and a net loss of $77.6 million. The company's committed backlog actually shrank 9.9% year-over-year to $1.14 billion, as existing contracts burned off faster than new ones were added.

Management has stated that achieving positive adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) requires annualized production of at least 100 megawatts, compared to roughly 30 megawatts today. The planned expansion of the Torrington, Connecticut manufacturing facility to 500 MW of capacity is expected to cost $200–$275 million — a significant capital outlay for a company that remains deeply unprofitable. An upsized stock offering of 10.7 million shares at $21 per share in July 2026 raised approximately $225 million but also diluted existing shareholders.

Wells Fargo maintains an Underweight rating, citing skepticism about FCEL's ability to secure large data center orders at the scale needed to justify its expanded production capacity. The gap between a 4-gigawatt pipeline of possibilities and actual signed contracts remains wide, and the timeline for converting proposals into revenue is uncertain.

What Wall Street Analysts Are Saying

Among nine Wall Street analysts covering FCEL, the consensus rating is Hold, with three Buy ratings, four Holds, and two Sell ratings. The average 12-month price target stands at approximately $22, though estimates range dramatically from $8 to $32. The wide dispersion reflects fundamental disagreement about whether the data center opportunity will materialize into profitable revenue or remain a compelling but ultimately unrealized narrative. The $25 level sits slightly above the consensus average and would require the bullish case to gain further traction — either through additional contract announcements or measurable progress in converting the existing pipeline.

Key Technical Levels to Watch

From a technical perspective, FCEL trades well below its 52-week high of $37.88 but has established a support zone near $16–$17, where buyers stepped in after the stock's sharp pullback from June highs. The $25 level represents a prior area of price consolidation and aligns with the psychological milestone of a round number. A sustained move above $25 would likely require clearing resistance near $21–$22, where the recent stock offering was priced. The broader trend structure remains upward on a multi-month view, though the stock's beta of 2.37 signals continued volatility that investors should expect along any path toward higher levels.

Using AI Tools to Monitor FCEL

I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry. Traders navigating FCEL's volatility can benefit from tools that monitor shifting market conditions in real time. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously analyze thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving technical patterns, market behavior, and AI-driven analysis. These signals help traders identify emerging opportunities, track active positions, and respond to changing trends without manually scanning endless charts. For those watching whether FCEL can reclaim the $25 level, systematic AI-driven monitoring offers a way to stay ahead of inflection points as they develop.

My Take: Is $25 Realistic for FCEL?

The $25 target for FuelCell Energy appears achievable but far from guaranteed. The company possesses a genuinely compelling growth narrative built around AI data center power demand, a 4-gigawatt pipeline, and at least one concrete partnership in Fit Energy that provides initial validation. Several prominent analysts see sufficient upside to justify Buy ratings and price targets at or above $25. However, the financial foundation remains weak: revenues are declining, losses are widening, and the transition from pipeline proposals to contracted revenue has not yet occurred at scale. Investors should monitor quarterly backlog figures, Fit Energy deployment milestones, and any additional data center partnership announcements — these data points will determine whether the path to $25 opens or closes. The story is high-risk and high-reward, and reaching $25 likely requires at least one major contract conversion that demonstrates the pipeline is more than just potential.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FCEL

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


FCEL's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for FCEL moved out of overbought territory on July 01, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 instances where the indicator moved out of the overbought zone. In of the 29 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where FCEL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FCEL as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FCEL turned negative on August 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

FCEL moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FCEL crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FCEL advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 154 cases where FCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.257) is normal, around the industry mean (8.806). P/E Ratio (0.000) is within average values for comparable stocks, (125.679). FCEL's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.368). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (4.933) is also within normal values, averaging (12.402).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.92B. The market cap for tickers in the group ranges from 457 to 300.34B. CYATY holds the highest valuation in this group at 300.34B. The lowest valued company is NXUR at 457.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was 6%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -10%. OESX experienced the highest price growth at 77%, while ELPW experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 71
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 82
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
FCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of installs and services fuel cell power plants for distributed power generation

Industry ElectricalProducts

Profile
Details
Industry
Industrial Machinery
Address
3 Great Pasture Road
Phone
+1 203 825-6000
Employees
424
Web
https://www.fuelcellenergy.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.